# Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus

> **NCT02496000** · PHASE2 · COMPLETED · sponsor: **Oramed, Ltd.** · enrollment: 188 (actual)

## Conditions studied

- Diabetes Type 2

## Interventions

- **DRUG:** ORMD-0801
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT02496000
- **Lead sponsor:** Oramed, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-27
- **Primary completion:** 2016-06-27
- **Final completion:** 2016-09-13
- **Target enrollment:** 188 (ACTUAL)
- **Last updated:** 2019-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02496000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02496000, "Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02496000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*